- Home
- MAPS vs SLN Comparison
MAPS vs SLN Comparison
Compare MAPS & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAPS
- SLN
- Stock Information
- Founded
- MAPS 2008
- SLN 1994
- Country
- MAPS United States
- SLN United Kingdom
- Employees
- MAPS N/A
- SLN N/A
- Industry
- MAPS Computer Software: Prepackaged Software
- SLN Biotechnology: Pharmaceutical Preparations
- Sector
- MAPS Technology
- SLN Health Care
- Exchange
- MAPS Nasdaq
- SLN Nasdaq
- Market Cap
- MAPS 131.9M
- SLN 123.3M
- IPO Year
- MAPS N/A
- SLN N/A
- Fundamental
- Price
- MAPS $1.04
- SLN $3.14
- Analyst Decision
- MAPS Strong Buy
- SLN Buy
- Analyst Count
- MAPS 1
- SLN 5
- Target Price
- MAPS $2.61
- SLN $40.80
- AVG Volume (30 Days)
- MAPS 774.3K
- SLN 292.1K
- Earning Date
- MAPS 05-23-2025
- SLN 05-15-2025
- Dividend Yield
- MAPS N/A
- SLN N/A
- EPS Growth
- MAPS N/A
- SLN N/A
- EPS
- MAPS 0.08
- SLN N/A
- Revenue
- MAPS $184,514,000.00
- SLN $43,258,000.00
- Revenue This Year
- MAPS $0.86
- SLN N/A
- Revenue Next Year
- MAPS $12.85
- SLN N/A
- P/E Ratio
- MAPS $13.10
- SLN N/A
- Revenue Growth
- MAPS N/A
- SLN 36.71
- 52 Week Low
- MAPS $0.70
- SLN $1.97
- 52 Week High
- MAPS $1.65
- SLN $24.38
- Technical
- Relative Strength Index (RSI)
- MAPS 37.34
- SLN 49.25
- Support Level
- MAPS $1.00
- SLN $2.63
- Resistance Level
- MAPS $1.11
- SLN $2.95
- Average True Range (ATR)
- MAPS 0.06
- SLN 0.43
- MACD
- MAPS -0.00
- SLN 0.11
- Stochastic Oscillator
- MAPS 29.17
- SLN 72.67
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.
About SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.